Madeline Layeghi

Madeline Layeghi

Auto-generated profile, based on publicly available information

Madeline Layeghi

Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2022 in Science
Verified
Journal Article
Closed access
RSRalf Schmidt
Ralf Schmidt
ZSZachary Steinhart
Zachary Steinhart
MLMadeline Layeghi
Madeline Layeghi
JFJacob W. Freimer
Jacob W. Freimer
RBRaymund Bueno
Raymund Bueno
AMAlex Marson
Alex Marson
Regulation of cytokine production in stimulated T cells can be disrupted in autoimmunity, immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine regulators requires both loss-of-function and gain-of-function studies, which have been challenging in primary human cells. We now report genome-wide CRISPR activation (CRISPRa) and interference (CRISPRi) screens in primary human T cells to identify gene networks controlling interleukin-2 (IL-2) and interferon-γ (IFN-γ) production. Arrayed CRISPRa confirmed key hits and enabled multiplexed secretome characterization, revealing reshaped cytokine responses. Coupling CRISPRa screening with single-cell RNA sequencing enabled deep molecular characterization of screen hits, revealing how perturbations tuned T cell activation and promoted cell states characterized by distinct cytokine expression profiles. These screens reveal genes that reprogram critical immune cell functions, which could inform the design of immunotherapies.